United States Infusion Systems Market Outlook to 2033 - Infusion Pumps and Infusion Pump Disposables
Summary
GlobalData’s “United States Infusion Systems Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Infusion Systems market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Infusion Pumps and Infusion Pump Disposables
The United States Infusion Systems Market report provides key information and data on -
Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
2023 company share and distribution share data for Infusion Systems Market.
Global corporate-level profiles of key companies operating within the United States Infusion Systems Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Infusion Systems is segmented as follows -
Infusion Pumps
Infusion Pump Disposables
Reasons to Buy
The United States Infusion Systems Market report helps you to develop -
Business strategies by identifying the key market segments poised for strong growth in the future.
Market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Understand the key distribution channels and what’s the most preferred mode of product distribution -
Identify, understand and capitalize.
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Infusion Systems Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Infusion Systems Market, United States
3.1 Infusion Systems Market, United States, Revenue ($m), 2018-2033
3.1.1 Infusion Pump Disposables Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Infusion Pumps Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Infusion Systems Market, United States, Volume (Units), 2018-2033
3.2.1 Infusion Pump Disposables Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Infusion Pumps Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Infusion Systems Market, United States, Average Price ($) , 2018-2033
3.4 Infusion Systems Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Infusion Systems Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Infusion Systems Market
4.1 B. Braun Melsungen AG
4.1.1 Company Overview
4.2 ICU Medical Inc
4.2.1 Company Overview
4.3 Baxter International Inc
4.3.1 Company Overview
4.4 Becton Dickinson and Co
4.4.1 Company Overview
5 Infusion Systems Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 ANI Pharma to Acquire Alimera Sciences for Approximately USD381 Million
6.2 Debt Offerings
6.2.1 Cardinal Health Raises USD650 Million in Public Offering of 5.125% Notes Due 2029
6.2.2 Cardinal Health Raises USD500 Million in Public Offering of 5.45% Notes Due 2034
6.3 Equity Offerings
6.3.1 TriSalus Life Sciences' Selling Shareholders to Raise USD0.77 Million in Secondary Offering of Shares
6.3.2 Trisalus Life Sciences Raises USD30 Million in Private Placement of Shares
6.4 Partnerships
6.4.1 3M to Enter into Co Development Agreement With HD Korea Shipbuilding & Offshore Engineering (KSOE)
6.4.2 KORU Medical Enters into Co-Development Agreement with Biopharmaceutical Company
7 Recent Developments
7.1 Corporate Communications
7.1.1 Aug 01, 2024: 3M Names Anurag Maheshwari as Executive Vice President and Chief Financial Officer
7.2.3 Jul 25, 2024: IRADIMED to Hold 2024 Second Quarter Financial Results Conference Call on August 1st
7.2.4 May 02, 2024: IRadimed Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
7.2.5 Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
7.2.6 Jan 23, 2024: 3M Delivers Strong Fourth-Quarter Results; Improves Operational Performance and Exceeds Earnings and Cash Flow Expectations
7.2.7 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors
7.2.8 Nov 03, 2023: Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
7.2.9 Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
7.2.10 Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
7.2.11 Sep 19, 2023: Baxter to Host Third-Quarter 2023 Financial Results Conference Call for Investors
7.3 Government and Public Interest
7.3.1 May 21, 2024: FDA Provides Clearance to IND Application for Type 1 Diabetes Therapy SAB-142 by SAB Biotherapeutics
7.3.2 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference
7.3.3 Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
7.3.4 Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
7.4 Product News
7.4.1 Oct 05, 2023: KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
7.4.2 Sep 05, 2023: GE Medical Systems, Ultrasound & Primary Care Diagnostics Receives an Additional 510(k) Clearance for Vscan Air
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
List of Tables
Table 1: Infusion Systems Market, United States, Revenue ($m), USD Constant, 2018-2033